News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
168,862 Results
Type
Article (31773)
Company Profile (12)
Press Release (137077)
Section
Business (51971)
Career Advice (364)
Deals (3231)
Drug Delivery (7)
Drug Development (23774)
Employer Resources (32)
FDA (3299)
Job Trends (3157)
News (80262)
Policy (4143)
Tag
Academia (2388)
Alliances (10812)
Alzheimer's disease (480)
Approvals (3300)
Artificial intelligence (33)
Best Places to Work (2648)
Breast cancer (56)
Cancer (387)
Cardiovascular disease (30)
Career advice (334)
CAR-T (27)
Cell therapy (74)
Clinical research (18164)
Collaboration (100)
COVID-19 (1164)
C-suite (75)
Data (457)
Diabetes (31)
Diagnostics (1614)
Earnings (6150)
Employer resources (29)
Events (17237)
Executive appointments (253)
FDA (3425)
Funding (117)
Gene editing (20)
Gene therapy (49)
GLP-1 (118)
Government (932)
Healthcare (5018)
Infectious disease (1183)
Inflammatory bowel disease (32)
Interviews (41)
IPO (1466)
Job creations (574)
Job search strategy (313)
Layoffs (30)
Legal (674)
Lung cancer (47)
Lymphoma (31)
Manufacturing (26)
Medical device (3001)
Medtech (3002)
Mergers & acquisitions (1788)
Metabolic disorders (84)
Neuroscience (549)
NextGen Class of 2024 (1787)
Non-profit (1690)
Northern California (433)
Obesity (36)
Opinion (26)
Ovarian cancer (21)
People (31778)
Phase I (5775)
Phase II (8341)
Phase III (5509)
Pipeline (91)
Postmarket research (956)
Preclinical (3012)
Press Release (25)
Radiopharmaceuticals (63)
Rare diseases (59)
Real estate (1270)
Regulatory (2835)
Research institute (1341)
Resumes & cover letters (23)
Southern California (333)
Startups (1101)
United States (3249)
Vaccines (180)
Date
Today (23)
Last 7 days (119)
Last 30 days (547)
Last 365 days (7467)
2024 (7451)
2023 (9246)
2022 (11480)
2021 (13223)
2020 (12765)
2019 (12112)
2018 (8981)
2017 (8685)
2016 (8883)
2015 (10228)
2014 (7801)
2013 (7578)
2012 (7533)
2011 (7545)
2010 (6766)
Location
Africa (260)
Arizona (35)
Asia (10254)
Australia (2580)
California (874)
Canada (289)
China (64)
Colorado (43)
Connecticut (45)
Europe (27335)
Florida (105)
Georgia (31)
Illinois (102)
Indiana (43)
Japan (25)
Maryland (93)
Massachusetts (545)
Michigan (27)
Minnesota (49)
New Jersey (232)
New York (249)
North Carolina (214)
Northern California (433)
Ohio (49)
Pennsylvania (171)
South America (288)
Southern California (333)
Texas (124)
Utah (25)
Washington State (95)
168,862 Results for "cardiff university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Molecules for Cancer
Immutep Limited announces a License Agreement with Cardiff University granting the Company exclusive rights to develop and commercialise anti-LAG-3 small molecules.
June 25, 2024
·
4 min read
Press Releases
Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial
December 10, 2024
·
7 min read
Biotech Beach
Cardiff Oncology to Present at the Jefferies Healthcare Conference
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a company presentation and 1x1 investor meetings at the Jefferies Healthcare Conference, which is taking place at the Marriott Marquis in New York from June 5-6, 2024.
May 29, 2024
·
1 min read
Biotech Beach
Cardiff Oncology to Present at Upcoming Investor Conferences in May 2024
Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, announced that company management will present at two upcoming investor conferences in May 2024.
May 13, 2024
·
1 min read
Press Releases
Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
November 19, 2024
·
4 min read
Press Releases
Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update
November 8, 2024
·
9 min read
Business
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, announced financial results for the first quarter ended March 31, 2024, and provided a business update.
May 2, 2024
·
12 min read
Business
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that it plans to release financial results for the first quarter ended March 31, 2024 on Thursday, May 2 after the close of trading.
April 25, 2024
·
1 min read
Press Releases
Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC
October 30, 2024
·
6 min read
Biotech Beach
Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024
Cardiff Oncology, Inc. (Nasdaq: CRDF) today announced publications of five abstracts that will be presented in a poster session at the American Association for Cancer Research (AACR) Annual Meeting, taking place from April 5-10, 2024, in San Diego, California.
March 6, 2024
·
6 min read
1 of 16,887
Next
